bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods
PUBLISHED ON August 12, 2021
August 12, 2021 (San Antonio, TX) bioAffinity Technologies, a privately held company focused on early diagnostics and cancer therapeutics, announced publication in the peer-reviewed Journal of Visualized Experiments (JoVE). The paper, entitled Quality-Controlled Sputum Analysis by Flow Cytometry, presents an efficient and effective method to analyze sputum on a flow cytometric platform, allowing for development of high-throughput diagnostic tests for lung cancer and other lung diseases.
read more